Showing results (281-290 of 354) with videos related to
Sort By:
Pageof 36
Cancer Chemotherapy and Pharmacology|January 1, 1995
Population pharmacokinetics of hydroxyurea in cancer patientsW G Tracewell, D L Trump, W P Vaughan, et al.Applied Optics|February 16, 2010
Transient thermal blooming of single and multiple short laser pulsesR G Buser, R S Rohde, P J Berger, et al.Journal of Medical Engineering & Technology|July 1, 1985
A versatile speech output communication aidA L Evans, R A Gowdie, D Keating, et al.Neuroscience Letters|July 17, 1990
Intraventricular infusions of antibodies to amyloid-beta-protein precursor impair the acquisition of a passive avoidance response in the ratE Doyle, M T Bruce, K C Breen, et al.Toxicon : Official Journal of the International Society on Toxinology|January 1, 1997
Assessment of an ovine antivenom raised against venom from the desert black cobra (Walterinnesia aegyptia)A K al-Asmari, I H al-Abdulla, R G Crouch, et al.Oncology|October 1, 1994
Cyclic sequential endocrine therapy for advanced breast cancer using a combination of tamoxifen and megestrol acetateD J Crawford, W D George, D C Smith, et al.Urologic Oncology|January 13, 2011
Phase II trial of oral 1,25-dihydroxyvitamin D (calcitriol) in hormone refractory prostate cancerJ L Osborn, G G Schwartz, D C Smith, et al.British Journal of Cancer|January 1, 1981
Oestrogen-receptor status and endocrine therapy of breast cancer: response rates and status stabilityR E Leake, L Laing, K C Calman, et al.Cancer Research|October 1, 1976
Flow microfluorometric patterns of human bone marrow and tumor cells in response to cancer chemotherapyA Krishan, S W Pitman, H N Tattersall, et al.Urology|August 11, 1998
A phase II trial of oral diethylstilbesterol as a second-line hormonal agent in advanced prostate cancerD C Smith, B G Redman, L E Flaherty, et al.Pageof 36